Paysign, Inc. (NASDAQ:PAYS – Get Free Report) insider Matthew Louis Lanford sold 25,360 shares of Paysign stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $3.96, for a total transaction of $100,425.60. Following the sale, the insider now owns 109,731 shares of the company’s stock, valued at approximately $434,534.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Paysign Price Performance
PAYS opened at $3.68 on Thursday. Paysign, Inc. has a 12 month low of $2.22 and a 12 month high of $5.59. The business has a 50-day moving average of $3.96 and a two-hundred day moving average of $4.34. The stock has a market capitalization of $197.06 million, a price-to-earnings ratio of 24.53 and a beta of 0.95.
Paysign (NASDAQ:PAYS – Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The firm had revenue of $15.26 million during the quarter, compared to the consensus estimate of $14.96 million. During the same period in the previous year, the firm earned $0.02 earnings per share. Equities research analysts anticipate that Paysign, Inc. will post 0.21 earnings per share for the current year.
Institutional Trading of Paysign
Wall Street Analyst Weigh In
Separately, Barrington Research restated an “outperform” rating and set a $7.00 target price on shares of Paysign in a research report on Monday, November 4th.
Read Our Latest Research Report on Paysign
Paysign Company Profile
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Further Reading
- Five stocks we like better than Paysign
- Top Biotech Stocks: Exploring Innovation Opportunities
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Tariff Troubles: 3 Stocks Planning Higher Prices
- Options Trading – Understanding Strike Price
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.